» Articles » PMID: 29751776

Negative Effects of a High Tumour Necrosis Factor-α Concentration on Human Gingival Mesenchymal Stem Cell Trophism: the Use of Natural Compounds As Modulatory Agents

Overview
Publisher Biomed Central
Date 2018 May 13
PMID 29751776
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Adult mesenchymal stem cells (MSCs) play a crucial role in the maintenance of tissue homeostasis and in regenerative processes. Among the different MSC types, the gingiva-derived mesenchymal stem cells (GMSCs) have arisen as a promising tool to promote the repair of damaged tissues secreting trophic mediators that affect different types of cells involved in regenerative processes. Tumour necrosis factor (TNF)-α is one of the key mediators of inflammation that could affect tissue regenerative processes and modify the MSC properties in in-vitro applications. To date, no data have been reported on the effects of TNF-α on GMSC trophic activities and how its modulation with anti-inflammatory agents from natural sources could modulate the GMSC properties.

Methods: GMSCs were isolated and characterized from healthy subjects. The effects of TNF-α were evaluated on GMSCs and on the well-being of endothelial cells. The secretion of cytokines was measured and related to the modification of GMSC-endothelial cell communication using a conditioned-medium method. The ability to modify the inflammatory response was evaluated in the presence of Ribes nigrum bud extract (RBE).

Results: TNF-α differently affected GMSC proliferation and the expression of inflammatory-related proteins (interleukin (IL)-6, IL-10, transforming growth factor (TGF)-β, and cyclooxygenase (COX)-2) dependent on its concentration. A high TNF-α concentration decreased the GMSC viability and impaired the positive cross-talk between GMSCs and endothelial cells, probably by enhancing the amount of pro-inflammatory cytokines in the GMSC secretome. RBE restored the beneficial effects of GMSCs on endothelial viability and motility under inflammatory conditions.

Conclusions: A high TNF-α concentration decreased the well-being of GMSCs, modifying their trophic activities and decreasing endothelial cell healing. These data highlight the importance of controlling TNF-α concentrations to maintain the trophic activity of GMSCs. Furthermore, the use of natural anti-inflammatory agents restored the regenerative properties of GMSCs on endothelial cells, opening the way to the use and development of natural extracts in wound healing, periodontal regeneration, and tissue-engineering applications that use MSCs.

Citing Articles

Advancements in Mesenchymal Stem Cell-Based Therapy for Enhancing Arteriovenous Fistula Patency.

Baranwal G, Mukhtar H, Kane J, Lemieux A, Misra S Int J Mol Sci. 2024; 25(23).

PMID: 39684430 PMC: 11641758. DOI: 10.3390/ijms252312719.


Multimaterial and multiscale scaffold for engineering enthesis organ.

Micalizzi S, Russo L, Giacomelli C, Montemurro F, De Maria C, Nencioni M Int J Bioprint. 2023; 9(5):763.

PMID: 37457943 PMC: 10339436. DOI: 10.18063/ijb.763.


Current Strategies for Promoting the Large-scale Production of Exosomes.

Qu Q, Fu B, Long Y, Liu Z, Tian X Curr Neuropharmacol. 2023; 21(9):1964-1979.

PMID: 36797614 PMC: 10514529. DOI: 10.2174/1570159X21666230216095938.


Extract Inhibits Periodontitis-Inducing Mediators in Lipopolysaccharide-Activated RAW 264.7 Cells.

Lee H, Lee S, Lee S, Choi B, Lee D Curr Issues Mol Biol. 2023; 45(1):538-554.

PMID: 36661522 PMC: 9858207. DOI: 10.3390/cimb45010036.


In Vitro and In Vivo Evaluation of a Cyclic LyP-1-Modified Nanosystem for Targeted Endostatin Delivery in a KYSE-30 Cell Xenograft Athymic Nude Mice Model.

Adeyemi S, Choonara Y Pharmaceuticals (Basel). 2022; 15(3).

PMID: 35337150 PMC: 8955112. DOI: 10.3390/ph15030353.


References
1.
Kizil C, Kyritsis N, Brand M . Effects of inflammation on stem cells: together they strive?. EMBO Rep. 2015; 16(4):416-26. PMC: 4388609. DOI: 10.15252/embr.201439702. View

2.
Tracey D, Klareskog L, Sasso E, Salfeld J, Tak P . Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther. 2007; 117(2):244-79. DOI: 10.1016/j.pharmthera.2007.10.001. View

3.
Imaizumi T, Itaya H, Fujita K, Kudoh D, Kudoh S, Mori K . Expression of tumor necrosis factor-alpha in cultured human endothelial cells stimulated with lipopolysaccharide or interleukin-1alpha. Arterioscler Thromb Vasc Biol. 2000; 20(2):410-5. DOI: 10.1161/01.atv.20.2.410. View

4.
Morand D, Davideau J, Clauss F, Jessel N, Tenenbaum H, Huck O . Cytokines during periodontal wound healing: potential application for new therapeutic approach. Oral Dis. 2016; 23(3):300-311. DOI: 10.1111/odi.12469. View

5.
Daniele S, Natali L, Giacomelli C, Campiglia P, Novellino E, Martini C . Osteogenesis Is Improved by Low Tumor Necrosis Factor Alpha Concentration through the Modulation of Gs-Coupled Receptor Signals. Mol Cell Biol. 2017; 37(8). PMC: 5376638. DOI: 10.1128/MCB.00442-16. View